Medication info
Duavive Tablet 0.45/20 mg

Duavive Tablet 0.45/20 mg

Prescription medicationTabletOral
Ingredient · strength
Conjugated Estrogens 4.29%›10.4895mg / 1 tabletBazedoxifene Acetate›22.56mg / 1 tablet
Manufacturer / importer
Pfizer Pharmaceuticals Korea Limited
Appearance
Pink film-coated extended-release tablet with a convex shape, marked with '0.45/20' on one side.
Packaging
30 tablets (15/tablet blister x 2)
Approval status
Active

MFDS item code 201403398 · Approved 2014.07.25

Summary

Main use
Treatment of menopausal vasomotor symptoms in women with an intact uterus; prevention of postmenopausal osteoporosis
Who takes it
Adults
Adult dose
1. Treatment of moderate to severe vasomotor symptoms associated with menopause Take 1 tablet once daily at the recommended dose. 2. Prevention of postmenopausal osteoporosis Take 1 tablet once daily at the recommended dose. 3. General administration information Take 1 tablet of this drug once daily, with or without food. Swallow the tablet whole; do not chew or crush it. 4. Recommendations for calcium and vitamin D supplementation Women taking this drug to prevent postmenopausal osteoporosis should add dietary supplements if their daily intake of calcium and/or vitamin D from food is inadequate. 5. Instructions for a missed dose If a dose of this drug is missed, advise the patient to take it as soon as remembered unless it is almost time for the next scheduled dose. Do not take 2 doses at the same time.

Ingredients

Importer
Pfizer Pharmaceuticals Korea Limited

Efficacy & effects

Treatment of menopausal vasomotor symptoms in women with an intact uterus; prevention of postmenopausal osteoporosis

  • Vasomotor symptoms
  • osteoporosis
View approved original text

This medication is used to treat moderate to severe vasomotor symptoms associated with menopause in women who have not undergone a hysterectomy and to prevent postmenopausal osteoporosis. During treatment, it is important to use the medication for the shortest duration possible, considering individual patient goals and risks, and to assess the continued need for treatment through regular clinical evaluations. When used for osteoporosis prevention, it should be prescribed cautiously only to women at high risk for osteoporosis, and non-estrogen medications should also be considered. This medication is effective in alleviating menopausal symptoms and in preventing osteoporosis.

How to take

Adult dose

1. Treatment of moderate to severe vasomotor symptoms associated with menopause Take 1 tablet once daily at the recommended dose. 2. Prevention of postmenopausal osteoporosis Take 1 tablet once daily at the recommended dose. 3. General administration information Take 1 tablet of this drug once daily, with or without food. Swallow the tablet whole; do not chew or crush it. 4. Recommendations for calcium and vitamin D supplementation Women taking this drug to prevent postmenopausal osteoporosis should add dietary supplements if their daily intake of calcium and/or vitamin D from food is inadequate. 5. Instructions for a missed dose If a dose of this drug is missed, advise the patient to take it as soon as remembered unless it is almost time for the next scheduled dose. Do not take 2 doses at the same time.

Precautions

This medication is used to regulate hormonal balance in postmenopausal women. Women taking this medication should not take additional estrogen. Women with a uterus should exercise extra caution to reduce the risk of endometrial cancer. In postmenopausal women, persistent or recurrent genital bleeding requires medical consultation and examination to rule out cancer. This drug should not be used for the purpose of preventing cardiovascular diseases or dementia, and especially in women over 65, the risk of dementia may increase. This medication may increase the risk of thrombosis, so it should be used cautiously in individuals with risk factors for thrombosis such as high blood pressure, diabetes, or obesity. Women with undiagnosed uterine bleeding, a history of breast cancer, a history of thrombosis, liver disorders, or who are pregnant or breastfeeding should not take this medication. Additionally, patients with hereditary lactose intolerance should avoid this medication. Women with specific conditions such as hypertension, hypertriglyceridemia, certain ophthalmic diseases, cholestatic jaundice, hypocalcemia, asthma, diabetes mellitus, migraine, or hepatic hemangioma should use this medication cautiously. While taking this medication, side effects such as dizziness, nausea, diarrhea, muscle spasms, throat pain, flush, vomiting, alopecia, rash, itching, chloasma, arthralgia, leg cramps, chest pain, tenderness, swelling, discharge, vaginal secretions, pelvic pain, weight changes, increased blood pressure, drowsiness, dry mouth, peripheral edema, elevated triglycerides, elevated ALT, elevated AST, vaginitis, depression, mood swings, and changes in libido may occur, and if serious thrombosis or visual disturbances occur, immediate medical consultation is required. Women who are pregnant or may become pregnant should not take this medication, and breastfeeding women are also advised against using this medication. This drug is not for use in children and the elderly, particularly women over 75 years of age, should be carefully considered for use. It is important to receive regular check-ups and consult with healthcare professionals for safe treatment while taking this medication. In the event of an overdose, there is no specific antidote, and appropriate treatment should be given based on symptoms. Lastly, this medication should be stored out of reach of children and kept away from moisture.

Side effects

Nausea, diarrhea, indigestion, upper abdominal pain, muscle spasms, throat pain, dizziness, oropharyngeal pain, facial flushing, upper abdominal pain, nausea, diarrhea, indigestion, muscle spasms, throat pain, dizziness, oropharyngeal pain, venous thromboembolism, vaginitis, angioedema, anaphylaxis, urticaria, glucose intolerance, hypocalcemia, dementia, depression, mood changes, changes in libido, irritability, migraines, headaches, irritability, exacerbation of epilepsy, worsening of chorea, intolerance to contact lenses, myocardial infarction, exacerbation of asthma, nausea, pancreatitis, ischemic colitis, vomiting, hair loss, hirsutism, rash, itching, melasma, erythema multiforme, erythema nodosum, arthralgia, leg cramps, chest pain, tenderness, distension, secretion, vaginal discharge, changes in cervical eversion and secretion, pelvic pain, weight changes, increased blood pressure, drowsiness, retinal venous thrombosis, deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, dry mouth, urticaria, rash, itching, muscle cramps, peripheral edema, increased triglycerides, elevated alanine aminotransferase, elevated aspartate aminotransferase, retinal hemorrhage, bradycardia, phlegm disorders, cough, asthma, shortness of breath, laryngitis, chest pain, pain, abdominal bloating, gastroesophageal reflux disease, dry skin, skin atrophy, sensory disturbances, restless legs syndrome, bruising, vulvar dryness, Meniere's disease, fractures, myalgia, shoulder rotator cuff syndrome, spinal canal stenosis, cerebral infarction, cerebral hemorrhage, pyelonephritis, fever, generalized edema, fatigue, allergic reactions, discomfort in the chest, leg pain, edema, facial swelling, changes in temperature sensation, lethargy, asthenia, inadequate efficacy, dermatitis, localized skin reactions, increased sweating, eczema, insomnia, leukocytosis, vomiting, gastritis, colon polyps, belching, vomiting, gastritis, belching, headache, dizziness, pharyngitis, palpitations, palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 15 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink film-coated extended-release tablet with a convex shape, marked with '0.45/20' on one side.

Package unit

30 tablets (15/tablet blister x 2)

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.